Skip to main content

Table 1 Baseline participant characteristics in CFAS I and CFAS II

From: Increasing prevalence of anticholinergic medication use in older people in England over 20 years: cognitive function and ageing study I and II

Demographic characteristics CFAS I (N = 7,635) CFAS II (N = 7,762)
Sex
 Male 3045 (39.9) 3534 (45.5)
 Female 4590 (60.1) 4228 (54.5)
Age
 64–69 1981 (25.9) 1939 (25.0)
 70–74 1776 (23.3) 1873 (24.1)
 75–79 1725 (22.6) 1624 (20.9)
 80–84 1308 (17.1) 1278 (16.5)
 85–89 615 (8.1) 737 (9.5)
 90+ 230 (3.0) 311 (4.0)
Centre
 Cambridgeshire 2601 (34.1) 2558 (33.0)
 Newcastle 2522 (33.0) 2582 (33.3)
 Nottingham 2512 (32.9) 2622 (33.8)
MMSE1
 Median (IQR) 27 (24, 28) 28 (26, 29)
Disability
 None 5236 (68.6) 4975 (64.1)
 IADL disability 1048 (13.7) 1495 (19.3)
 ADL-IADL disability 1267 (16.6) 981 (12.6)
Residence
 Community-dwelling 7245 (94.9) 7565 (97.5)
 Long term care 242 (3.2) 197 (2.5)
  1. Cell entries denote n (%) unless otherwise specified
  2. 1139 and 255 participants had missing MMSE data in CFAS I and CFAS II
  3. Abbreviations: CFAS Cognitive Function and Ageing Studies, CI confidence interval, MMSE Mini-Mental State Examination, ADL activities of daily living, IADL instrumental activities of daily living, SD standard deviation, IQR Interquartile range